BRIEF published on 01/07/2026 at 19:17, 4 months 9 days ago Bilan semestriel du contrat de liquidité d'ABIONYX Pharma Contrat De Liquidité TP ICAP Europe Transactions Boursières ABIONYX Pharma Actions Et Espèces
PRESS RELEASE published on 01/07/2026 at 19:12, 4 months 9 days ago Inside Information / Other news releases ABIONYX Pharma releases half-yearly report on liquidity contract with TP ICAP (Europe) SA, detailing shares and cash balance for 2025 Liquidity Contract Shares TP ICAP Cash Balance ABIONYX Pharma
PRESS RELEASE published on 01/07/2026 at 19:12, 4 months 9 days ago Informations privilégiées / Autres communiqués Bilan semestriel du contrat de liquidité d'ABIONYX Pharma avec TP ICAP (Europe) SA : achat de 437 203 titres pour 1 389 323,53€ et vente de 536 477 titres pour 1 560 333,66€ Contrat De Liquidité TP ICAP Achat Vente ABIONYX Pharma
BRIEF published on 12/16/2025 at 21:23, 5 months ago ABIONYX Pharma Announces €1.8 Million Capital Increase Capital Increase Subscription Rights Euronext Listing ABIONYX Pharma Financial Visibility
BRIEF published on 12/16/2025 at 21:23, 5 months ago ABIONYX Pharma Annonce une Augmentation de Capital Augmentation De Capital Biopharmaceutique Levée De Fonds ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 5 months ago ABIONYX Pharma Announces a Capital Increase Fundraising Capital Increase Biopharmaceutical ABIONYX Pharma Sepsis
BRIEF published on 12/16/2025 at 21:23, 5 months ago ABIONYX Pharma annonce une augmentation de capital de 1,8 million d'euros. Augmentation De Capital Cotation Euronext Visibilité Financière ABIONYX Pharma Droits D'abonnement
PRESS RELEASE published on 12/16/2025 at 21:18, 5 months ago Inside Information / Other news releases ABIONYX Pharma launches €1.8m capital increase with removal of preferential subscription rights, subscription price at 3.10 euros for new shares, extending financial visibility until 2026 Capital Increase Biopharma Preferential Subscription Rights ABIONYX Pharma Financial Visibility
PRESS RELEASE published on 12/16/2025 at 21:18, 5 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma lance une augmentation de capital de 1,8M€ avec suppression du droit préférentiel de souscription à 3,10 euros par action et extension de la visibilité jusqu'à fin 2026 Augmentation De Capital Droit Préférentiel De Souscription ABIONYX Pharma Visibilité 3,10 Euros
BRIEF published on 12/05/2025 at 18:05, 5 months 11 days ago ABIONYX publie des données mensuelles sur les droits de vote et les actions Euronext Paris Capital Social Droit De Vote ABIONYX Pharma Règlementation De L'AMF
Published on 05/16/2026 at 01:15, 1 day 6 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 8 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 9 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 9 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 16 hours 5 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 12 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 14 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 17 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 17 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 22 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 23 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 14 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
